An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysis

Abstract Background Angiotensin-converting enzyme-2 (ACE2) acts as a key regulatory molecule and important therapeutic target in the pathological remodeling of numerous organs and diseases. In this study, a rapid, simple, and efficient synthetic route with a catalytic, 18F-for-Cl (18F/Cl) exchange s...

Full description

Saved in:
Bibliographic Details
Main Authors: Pan Zhou, Kai Ning, Shuai Xue, Qingqing Li, Danni Li, Haijun Yang, Zeying Liang, Rou Li, Jian Yang, Xiao Li, Lan Zhang
Format: Article
Language:English
Published: SpringerOpen 2024-12-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Online Access:https://doi.org/10.1186/s41181-024-00316-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846136691148980224
author Pan Zhou
Kai Ning
Shuai Xue
Qingqing Li
Danni Li
Haijun Yang
Zeying Liang
Rou Li
Jian Yang
Xiao Li
Lan Zhang
author_facet Pan Zhou
Kai Ning
Shuai Xue
Qingqing Li
Danni Li
Haijun Yang
Zeying Liang
Rou Li
Jian Yang
Xiao Li
Lan Zhang
author_sort Pan Zhou
collection DOAJ
description Abstract Background Angiotensin-converting enzyme-2 (ACE2) acts as a key regulatory molecule and important therapeutic target in the pathological remodeling of numerous organs and diseases. In this study, a rapid, simple, and efficient synthetic route with a catalytic, 18F-for-Cl (18F/Cl) exchange scheme was designed for the preparation of 18F-labeled MLN-4760, and its targeting ability was investigated in a humanized ACE2 mouse model. Results A novel 18F-labeled MLN-4760 radioligand, abbreviated as 18F-MLN-4760, was successfully synthesized by the 18F/Cl exchange-labeling, and was purified by SepPak C18 columns with a radiochemical yield of 30% and a radiochemical purity of 29.89%. Target distribution of 18F-MLN-4760 in several organs with high ACE2 expression was observed by PET imaging with good stability over 120 min. The biodistribution data showed that the uptake of 18F-MLN-4760 in ACE2-overexpressing organs and tissues was highly specific, and immunohistochemistry confirmed the same results of ACE2 expression and biodistribution in the major organs (heart, liver, lungs, and kidneys). There was a good correlation between the uptake in the organs with high ACE2 expression and ACE2 expression levels (r = 0.935). Conclusion 18F-MLN-4760 was successfully synthesized via 18F/Cl exchange under phase transfer catalysis, and served as a potential probe for ACE2-targeted PET imaging.
format Article
id doaj-art-468e2eb0332941ad8b5f9c7f213eecf9
institution Kabale University
issn 2365-421X
language English
publishDate 2024-12-01
publisher SpringerOpen
record_format Article
series EJNMMI Radiopharmacy and Chemistry
spelling doaj-art-468e2eb0332941ad8b5f9c7f213eecf92024-12-08T12:50:00ZengSpringerOpenEJNMMI Radiopharmacy and Chemistry2365-421X2024-12-019111110.1186/s41181-024-00316-5An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysisPan Zhou0Kai Ning1Shuai Xue2Qingqing Li3Danni Li4Haijun Yang5Zeying Liang6Rou Li7Jian Yang8Xiao Li9Lan Zhang10Department of Nuclear Medicine, Shanghai Changhai HospitalArtery PharmaceuticalsShanghai Institute of Applied Physics, Chinese Academy of SciencesArtery PharmaceuticalsDepartment of Nuclear Medicine, Shanghai Changhai HospitalSchool of Medicine, Shanghai UniversitySchool of Medicine, Shanghai UniversityDepartment of Nuclear Medicine, Shanghai Changhai HospitalSchool of Medicine, Shanghai UniversityDepartment of Nuclear Medicine, Shanghai Changhai HospitalShanghai Institute of Applied Physics, Chinese Academy of SciencesAbstract Background Angiotensin-converting enzyme-2 (ACE2) acts as a key regulatory molecule and important therapeutic target in the pathological remodeling of numerous organs and diseases. In this study, a rapid, simple, and efficient synthetic route with a catalytic, 18F-for-Cl (18F/Cl) exchange scheme was designed for the preparation of 18F-labeled MLN-4760, and its targeting ability was investigated in a humanized ACE2 mouse model. Results A novel 18F-labeled MLN-4760 radioligand, abbreviated as 18F-MLN-4760, was successfully synthesized by the 18F/Cl exchange-labeling, and was purified by SepPak C18 columns with a radiochemical yield of 30% and a radiochemical purity of 29.89%. Target distribution of 18F-MLN-4760 in several organs with high ACE2 expression was observed by PET imaging with good stability over 120 min. The biodistribution data showed that the uptake of 18F-MLN-4760 in ACE2-overexpressing organs and tissues was highly specific, and immunohistochemistry confirmed the same results of ACE2 expression and biodistribution in the major organs (heart, liver, lungs, and kidneys). There was a good correlation between the uptake in the organs with high ACE2 expression and ACE2 expression levels (r = 0.935). Conclusion 18F-MLN-4760 was successfully synthesized via 18F/Cl exchange under phase transfer catalysis, and served as a potential probe for ACE2-targeted PET imaging.https://doi.org/10.1186/s41181-024-00316-5MLN−4760ACE218F/Cl exchangePET imaging agentPhase transfer catalysis
spellingShingle Pan Zhou
Kai Ning
Shuai Xue
Qingqing Li
Danni Li
Haijun Yang
Zeying Liang
Rou Li
Jian Yang
Xiao Li
Lan Zhang
An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysis
EJNMMI Radiopharmacy and Chemistry
MLN−4760
ACE2
18F/Cl exchange
PET imaging agent
Phase transfer catalysis
title An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysis
title_full An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysis
title_fullStr An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysis
title_full_unstemmed An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysis
title_short An ACE2 PET imaging agent derived from 18F/Cl exchange of MLN-4760 under phase transfer catalysis
title_sort ace2 pet imaging agent derived from 18f cl exchange of mln 4760 under phase transfer catalysis
topic MLN−4760
ACE2
18F/Cl exchange
PET imaging agent
Phase transfer catalysis
url https://doi.org/10.1186/s41181-024-00316-5
work_keys_str_mv AT panzhou anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT kaining anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT shuaixue anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT qingqingli anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT dannili anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT haijunyang anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT zeyingliang anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT rouli anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT jianyang anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT xiaoli anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT lanzhang anace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT panzhou ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT kaining ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT shuaixue ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT qingqingli ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT dannili ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT haijunyang ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT zeyingliang ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT rouli ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT jianyang ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT xiaoli ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis
AT lanzhang ace2petimagingagentderivedfrom18fclexchangeofmln4760underphasetransfercatalysis